Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Fendrich

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Annals of Surgery|December 6, 2005
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1Detlef K Bartsch, Volker Fendrich, Peter Langer, et al.
Neoplasia (New York, N.Y.)|March 16, 2011
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Ralph Schneider, Anirban Maitra, et al.
International Journal of Molecular Sciences|January 25, 2013
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problemsGabriele Capurso, Volker Fendrich, Maria Rinzivillo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2015
C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine NeoplasiaDominik Wiese, Katharina Kampe, Jens Waldmann, et al.
Pancreas|December 24, 2010
Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entityRalph Schneider, Jens Waldmann, Zaher Swaid, et al.
Annals of Surgery|November 24, 2006
An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumorsVolker Fendrich, Peter Langer, Ilhan Celik, et al.
Neuroendocrinology|March 8, 2007
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic targetDorothee Karhoff, Susanne Sauer, Jörg Schrader, et al.
Langenbeck'S Archives of Surgery|August 2, 2011
Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1Caroline L Lopez, Jens Waldmann, Volker Fendrich, et al.
Neuroendocrinology|August 30, 2017
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small IntestineAnna E Heverhagen, Nathalie Legrand, Vinona Wagner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 1, 2013
Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Moritz Sparn, Matthias Lauth, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Annals of Surgery|December 6, 2005
Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1Detlef K Bartsch, Volker Fendrich, Peter Langer, et al.
Neoplasia (New York, N.Y.)|March 16, 2011
Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Ralph Schneider, Anirban Maitra, et al.
International Journal of Molecular Sciences|January 25, 2013
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problemsGabriele Capurso, Volker Fendrich, Maria Rinzivillo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 19, 2015
C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine NeoplasiaDominik Wiese, Katharina Kampe, Jens Waldmann, et al.
Pancreas|December 24, 2010
Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entityRalph Schneider, Jens Waldmann, Zaher Swaid, et al.
Annals of Surgery|November 24, 2006
An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumorsVolker Fendrich, Peter Langer, Ilhan Celik, et al.
Neuroendocrinology|March 8, 2007
Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic targetDorothee Karhoff, Susanne Sauer, Jörg Schrader, et al.
Langenbeck'S Archives of Surgery|August 2, 2011
Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1Caroline L Lopez, Jens Waldmann, Volker Fendrich, et al.
Neuroendocrinology|August 30, 2017
Overexpression of MicroRNA miR-7-5p Is a Potential Biomarker in Neuroendocrine Neoplasms of the Small IntestineAnna E Heverhagen, Nathalie Legrand, Vinona Wagner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|October 1, 2013
Simvastatin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerVolker Fendrich, Moritz Sparn, Matthias Lauth, et al.
Pageof 11